Companies / India
Wockhardt Acquires Negma
May 2007 | Industry NewsIndian biotech firm Wockhardt has acquired French pharmaceutical company Negma Laboratories for US$265mn. The deal makes Wockhardt the largest Indian drugmaker operating in Europe. Europe, with is appetite for low-cost generic products and high levels of health expenditure, is seen as a key target for Indian firms, especially considering the difficult operating environments currently being experienced by generics firms in the US.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
